FDA Inspection
Andre Kalil, M.D.Andre Kalil, M.D. – FDA Inspection, Jan 14, 2022
Record Details
This FDA Inspection record concerns Andre Kalil, M.D., with an inspection on January 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Andre Kalil, M.D.
- Inspection Date
- January 14, 2022
- Product Type
- Drugs
View Company Profile
ID · 844d2586-f28d-4f9e-9221-d7d6adc85f8e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1161197
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 50.27(a)Consent form not approved/signed/dated
- 21 CFR 50.20Circumstances of obtaining consent
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.